Citation Impact
Citing Papers
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
2002 StandoutScienceNobel
N,N-Dimethyltryptamine: An Endogenous Hallucinogen
1981
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
2003
Medical Therapy For Pulmonary Arterial Hypertension
2004
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo
2010
Antithrombotic Therapy for VTE Disease
2016 Standout
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension
2004
S-Adenosyl-L-methionine restores prolactin receptors in the aged rabbit brain
1989
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
1995
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Dose-Response Study of N,N-Dimethyltryptamine in Humans
1994
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Dose-Response Study of N,N-Dimethyltryptamine in Humans
1994
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
An application of prefrontal cortex function theory to cognitive aging.
1996 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro
1998
Insights into the ageing mind: a view from cognitive neuroscience
2004 Standout
Sleep Deprivation Effects on Circadian Clock Gene Expression in the Cerebral Cortex Parallel Electroencephalographic Differences among Mouse Strains
2008 StandoutNobel
Cyclic nucleotide research — still expanding after half a century
2002 Standout
Kinetics of nitric oxide‐cyclic GMP signalling in CNS cells and itspossible regulation by cyclic GMP
2002
From sensation to cognition
1998 Standout
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Pharmacological Studies on (4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-Ethoxycarbonyl-3-Phenylpropyl)amino] Propionyl}-2-Oxolmidazolidine-4-Carboxylic Acid Hydrochloride (TA-6366), a New ACE Inhibitor: I. ACE Inhibitory and Anti-Hypertensive Activities
1990
Enoximone
1991
Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment Paradigm
2006
Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
1995
Idiopathic pulmonary fibrosis
2011 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Age-related changes in histamine receptor mRNA levels in the mouse brain
2003
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
2002
Structure-specific Inhibition of Cholesteryl Ester Transfer Protein by Azaphilones.
1999 StandoutNobel
Introduction
2004
Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension
2003
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
2005
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Reduced dopaminergic binding during aging in the rodent striatum
1980
5-Methyltetrahydrofolic Acid as a Mediator in the Formation of Pyridoindoles
1974 Science
In Vivo Assessment of Local Phosphodiesterase Activity Using Tailored Cyclic Nucleotide–Gated Channels as Camp Sensors
2001
Tryptoline Formation by a Preparation from Brain with 5-Methyltetrahydrofolic Acid and Tryptamine
1975 Science
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
2002
Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.
1980 Standout
Pulmonary Arterial Hypertension
2006
β-receptors during aging in respiratory tissues
1982
Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys
1981
puberty of female rats may in part be explained by decreased hypothalamic dopamine receptor sensitivity
1981
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
Regulation of Prolactin Secretion at the Pituitary Level
1981
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.
1981
Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp
2004
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
The Design and Properties of N‐Carboxyalkyldipeptide Inhibitors of Angiotensin‐Converting Enzyme
1985
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine
1976
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Central neurotransmitters and aging
1980
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
2005
Muscarinic and dopaminergic receptors in the aging human brain
1987
Lipopolysaccharide Endotoxins
2002 Standout
The Impact of Aging on Adrenergic Receptor Function: Clinical and Biochemical Aspects
1985 StandoutNobel
Upregulation of Phosphodiesterase 1A1 Expression Is Associated With the Development of Nitrate Tolerance
2001
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Altered neuronal responsiveness to biogenic amines in rat cerebral cortex after serotonin denervation or depletion
1982
Age-related behavioral and neurobiological changes: A review with an emphasis on memory
1981
Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation
1984 StandoutScience
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
1983 Standout
Cardiac Mitogen-Activated Protein Kinase Activities Are Chronically Increased in Stroke-Prone Hypertensive Rats
1998 StandoutNobel
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases
1995
AN INTEGRATIVE THEORY OF LOCUS COERULEUS-NOREPINEPHRINE FUNCTION: Adaptive Gain and Optimal Performance
2005 Standout
The Inhibition of Phosphatidylinositol Turnover: A Possible Postreceptor Mechanism for the Prolactin Secretion-Inhibiting Effect of Dopamine*
1983
Dopamine Receptors: From Structure to Function
1998 Standout
Recent developments in the design of angiotensin‐converting enzyme inhibitors
1985
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 StandoutScience
Hallucinogens
2004 Standout
Works of Ho Sam Ahn being referenced
Ca/CaM-Stimulated and cGMP-Specific Phosphodiesterases in Vascular and Non-Vascular Tissues
1991
Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta
1989
Antihypertensive Activity of SCH 31846, a Non-Sulfhydryl Angiotensin-Converting Enzyme Inhibitor
1983
Aging and monoamine receptors in brain.
1979
Neurotransmitter-sensitive adenylate cyclase in the hypothalami of guinea-pig, rat and monkey
1977
Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: Regional differences
1979
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism
1986
Anterior pituitary adenylate cyclase: Stimulation by dopamine and other monoamines
1979
Biogenic Amine-Stimulated Adenylate Cyclase and Spiroperidol-Binding Sites in Rabbit Brain: Evidence for Selective Loss of Receptors with Aging
1978
Angiotensin-Converting Enzyme Inhibitory Activity of SCH 31846, a New Non-Sulfhydryl Inhibitor
1983
Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging
1980
Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients
1973
Stimulation of adenylate cyclase activity in monkey anterior limbic cortex by serotonin
1978
Identification of N,N-dimethyltryptamine as the product of an in vitro enzymic methylation
1972
Catecholamine-sensitive adenylate cyclase in frontal cortex of primate brain
1976
Indoleamine-N-methyl transferase in human lung
1972
ChemInform Abstract: Wiedendiol‐A and ‐B, Cholesteryl Ester Transfer Protein Inhibitors from the Marine Sponge Xestospongia wiedenmayeri.
1995
BLOOD AND URINARY DIMETHYLTRYPTAMINE IN ACUTE PSYCHOTIC DISORDERS
1974
3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regions
1978